Shares Up as Epocrates Conducts IPO
Shares in drug reference content software vendor Epocrates Inc. rose more than 20 percent soon after trading started for its initial public offering of stock on Feb. 2.
Shares in drug reference content software vendor Epocrates Inc. rose more than 20 percent soon after trading started for its initial public offering of stock on Feb. 2.
The San Mateo, Calif.-based company raised its price before trading started from $13-15 to $16 per share. That raised the potential value of the IPO to $98.6 million. Epocrates' technology enables clinicians to access drug information via mobile computing devices at the point of care.
More information is available at epocrates.com.
--Joseph Goedert
The San Mateo, Calif.-based company raised its price before trading started from $13-15 to $16 per share. That raised the potential value of the IPO to $98.6 million. Epocrates' technology enables clinicians to access drug information via mobile computing devices at the point of care.
More information is available at epocrates.com.
--Joseph Goedert
More for you
Loading data for hdm_tax_topic #better-outcomes...